Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiloride for lithium-induced nephrogenic diabetes insipidus in bipolar disorder
2021-003600-41Phase 2Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of amiloride in Arginine Vasopressin Resistance (AVP-R) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2021; status: active.
02
Drugs
amiloride
03
Conditions
Arginine Vasopressin Resistance (AVP-R)
Beyond the preview
Go deeper on 2021-003600-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003600-41.